Novo Ventures and HBM Partners have led a CHF 100m series-C funding round for Switzerland-based Numab Therapeutics, a multi-specific antibodies developer.
GP acquired the human-machine interface (HMI) software and hardware developer in 2017
Unquote catches up with managing partner David Burns to discuss recent activity and where the firm is headed next
Advisory firm BDO reviewed the ESG policies of 100 private equity firms with UK operations
Teasers for the Italian orthopaedic prosthetics producer were dispatched recently, sources say